塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/17 | 6,075 | 6,149 | 6,070 | 6,126 | +34 | +0.6% | 996,300 |
2023/04/14 | 6,088 | 6,115 | 6,072 | 6,092 | +19 | +0.3% | 1,071,400 |
2023/04/13 | 6,022 | 6,080 | 6,013 | 6,073 | +28 | +0.5% | 756,800 |
2023/04/12 | 6,028 | 6,068 | 6,024 | 6,045 | +21 | +0.3% | 781,400 |
2023/04/11 | 6,017 | 6,064 | 6,003 | 6,024 | +17 | +0.3% | 814,800 |
2023/04/10 | 5,996 | 6,024 | 5,981 | 6,007 | +37 | +0.6% | 556,400 |
2023/04/07 | 6,019 | 6,022 | 5,970 | 5,970 | -28 | -0.5% | 642,400 |
2023/04/06 | 5,960 | 6,005 | 5,940 | 5,998 | +34 | +0.6% | 987,800 |
2023/04/05 | 6,091 | 6,096 | 5,949 | 5,964 | -84 | -1.4% | 1,021,300 |
2023/04/04 | 6,018 | 6,052 | 5,992 | 6,048 | +73 | +1.2% | 966,200 |
2023/04/03 | 5,980 | 6,042 | 5,971 | 5,975 | -2 | ±0% | 923,500 |
2023/03/31 | 5,980 | 5,980 | 5,930 | 5,977 | +34 | +0.6% | 1,362,100 |
2023/03/30 | 5,926 | 5,964 | 5,913 | 5,943 | -62 | -1% | 1,206,000 |
2023/03/29 | 5,964 | 6,007 | 5,944 | 6,005 | +44 | +0.7% | 1,176,500 |
2023/03/28 | 5,981 | 6,002 | 5,924 | 5,961 | ±0 | ±0% | 694,800 |
2023/03/27 | 5,899 | 5,969 | 5,884 | 5,961 | +94 | +1.6% | 910,400 |
2023/03/24 | 5,850 | 5,883 | 5,821 | 5,867 | +2 | ±0% | 743,000 |
2023/03/23 | 5,900 | 5,902 | 5,846 | 5,865 | -83 | -1.4% | 977,200 |
2023/03/22 | 5,960 | 5,991 | 5,906 | 5,948 | +88 | +1.5% | 1,355,100 |
2023/03/20 | 5,901 | 5,944 | 5,860 | 5,860 | -79 | -1.3% | 952,400 |
2023/03/17 | 5,970 | 5,983 | 5,917 | 5,939 | +33 | +0.6% | 1,549,800 |
2023/03/16 | 5,879 | 5,908 | 5,847 | 5,906 | -51 | -0.9% | 1,203,800 |
2023/03/15 | 6,000 | 6,005 | 5,934 | 5,957 | -28 | -0.5% | 1,065,100 |
2023/03/14 | 5,978 | 6,029 | 5,908 | 5,985 | -63 | -1% | 1,524,400 |
2023/03/13 | 6,041 | 6,090 | 6,026 | 6,048 | -78 | -1.3% | 979,700 |
2023/03/10 | 6,157 | 6,205 | 6,122 | 6,126 | -117 | -1.9% | 1,716,100 |
2023/03/09 | 6,256 | 6,260 | 6,206 | 6,243 | +48 | +0.8% | 1,317,500 |
2023/03/08 | 6,129 | 6,206 | 6,128 | 6,195 | +69 | +1.1% | 1,486,900 |
2023/03/07 | 6,101 | 6,134 | 6,088 | 6,126 | +60 | +1% | 1,204,700 |
2023/03/06 | 6,060 | 6,082 | 6,028 | 6,066 | +27 | +0.4% | 1,126,300 |
2023/03/03 | 6,006 | 6,056 | 5,966 | 6,039 | +66 | +1.1% | 1,700,400 |
2023/03/02 | 5,955 | 5,996 | 5,946 | 5,973 | +28 | +0.5% | 1,192,300 |
2023/03/01 | 6,046 | 6,050 | 5,925 | 5,945 | -114 | -1.9% | 1,866,000 |
2023/02/28 | 6,113 | 6,140 | 6,052 | 6,059 | -46 | -0.8% | 1,562,400 |
2023/02/27 | 6,143 | 6,149 | 6,081 | 6,105 | -41 | -0.7% | 1,052,900 |
2023/02/24 | 6,119 | 6,146 | 6,076 | 6,146 | +41 | +0.7% | 1,297,100 |
2023/02/22 | 6,081 | 6,114 | 6,013 | 6,105 | -11 | -0.2% | 2,391,300 |
2023/02/21 | 6,139 | 6,161 | 6,116 | 6,116 | -44 | -0.7% | 855,700 |
2023/02/20 | 6,209 | 6,230 | 6,153 | 6,160 | +13 | +0.2% | 781,400 |
2023/02/17 | 6,190 | 6,193 | 6,127 | 6,147 | -80 | -1.3% | 1,778,200 |
2023/02/16 | 6,262 | 6,271 | 6,225 | 6,227 | -67 | -1.1% | 1,474,000 |
2023/02/15 | 6,350 | 6,350 | 6,270 | 6,294 | -25 | -0.4% | 1,053,700 |
2023/02/14 | 6,300 | 6,333 | 6,286 | 6,319 | +53 | +0.8% | 1,174,500 |
2023/02/13 | 6,212 | 6,275 | 6,212 | 6,266 | +19 | +0.3% | 973,700 |
2023/02/10 | 6,279 | 6,300 | 6,204 | 6,247 | +15 | +0.2% | 1,496,500 |
2023/02/09 | 6,255 | 6,261 | 6,195 | 6,232 | -20 | -0.3% | 1,550,900 |
2023/02/08 | 6,318 | 6,322 | 6,236 | 6,252 | -43 | -0.7% | 1,321,900 |
2023/02/07 | 6,315 | 6,405 | 6,289 | 6,295 | +66 | +1.1% | 1,979,400 |
2023/02/06 | 6,266 | 6,282 | 6,223 | 6,229 | +22 | +0.4% | 1,543,400 |
2023/02/03 | 6,192 | 6,254 | 6,176 | 6,207 | +14 | +0.2% | 1,565,700 |
501~
550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 237,000円 | +5.7% | +3.9% | 2.59% | 11.79倍 | 1.56倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 736,300円 | +2.2% | +10.2% | 1.63% | 14.14倍 | 1.43倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 142,800円 | +0.9% | +380.2% | 5.46% | 19.67倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 408,400円 | +1.7% | -2.9% | 3.92% | 26.79倍 | 1.41倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 210,300円 | -3.5% | -11.3% | 2.85% | 19.31倍 | 1.30倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム